The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-cell profiling of human heart and blood in immune checkpoint inhibitor-associated myocarditis.
 
Steven Michael Blum
Stock and Other Ownership Interests - 76Bio; Alimera Sciences; Kronos Bio
 
Daniel A. Zlotoff
Consulting or Advisory Role - Bristol-Myers Squibb; Freeline Therapeutics; Intrinsic Imaging
 
Neal Smith
No Relationships to Disclose
 
Swetha Ramesh
No Relationships to Disclose
 
Isabela Kernin
No Relationships to Disclose
 
Pritha Sen
No Relationships to Disclose
 
Leyre Zubiri
Consulting or Advisory Role - Merck
 
Alice Tirard
No Relationships to Disclose
 
Mazen Nasrallah
Patents, Royalties, Other Intellectual Property - PSO-MRI
 
Jessica Tantivit
No Relationships to Disclose
 
Jaimie Lynn Barth
No Relationships to Disclose
 
Dejan Juric
Stock and Other Ownership Interests - PIC Therapeutics; Relay Therapeutics; Vibliome Therapeutics
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; MapKure; Novartis; Petra Pharma; PIC Therapeutics; Relay Therapeutics; Silverback Therapeutics; Syros Pharmaceuticals; Vibliome Therapeutics
Research Funding - Amgen (Inst); Eisai (Inst); EMD Serono (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Novartis (Inst); Pfizer (Inst); Placon (Inst); Syros Pharmaceuticals (Inst); Takeda (Inst); Takeda (Inst)
 
Ryan J. Sullivan
Consulting or Advisory Role - alkermes; Asana Biosciences; AstraZeneca; Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck; Novartis; OncoSec; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Viralytics (Inst)
 
Genevieve Marie Boland
Stock and Other Ownership Interests - Ankyra Therapeutics
Honoraria - Novartis; Takeda
Consulting or Advisory Role - Ankyra Therapeutics; InterVenn Biosciences; Iovance Biotherapeutics; Merck; Northwest Biotherapeutics
Research Funding - InterVenn Biosciences; Olink; Palleon Pharmaceuticals; Takeda; Takeda
Other Relationship - Nektar; Novartis
 
Mari Mino-Kenudson
Honoraria - BMS; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; H3 Biomedicine
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Elsevier
 
James Stone
No Relationships to Disclose
 
Molly Thomas
No Relationships to Disclose
 
Kerry Lynn Reynolds
Employment - Project Data Sphere; Teladoc
Stock and Other Ownership Interests - Biogen (I)
Other Relationship - Project Data Sphere
 
Tomas G. Neilan
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; C4 Therapeutics; C4 Therapeutics; Eisai; Intrinsic Imaging; Parexel; Roche/Genentech; Sanofi
Research Funding - AstraZeneca
 
Alexandra-Chloé Villani
No Relationships to Disclose